NEW YORK (GenomeWeb) – Genesis Healthcare, a Tokyo-based provider of consumer genomics and clinical tests to the Japanese market, recently moved to the Affymetrix platform to support its offerings.

Iri Sato-Baran, president and chief strategy and research officer at Genesis Healthcare, told BioArray News that her company had used Illumina arrays in the past, but decided to adopt a custom Affymetrix-made Axiom genotyping array for diverse reasons earlier this year.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.